PCNA and neoplasm: Studies have reported that luteolin downregulates lymphocyte function-related molecules (LFA-3) and PCNA and upregulates intercellular adhesion molecule-1 (ICAM-1) in a way that inhibits tumor angiogenesis and tumor cell proliferation to achieve the anti-tumor effect of LUT 76(Figure 5A).